Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)
Clinical trial NCT07737106 · COMPLETED
Trial details
- NCT number
- NCT07737106
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-21
- Primary completion
- 2025-09-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.